Thursday - June 18, 2026

Category Archives: Science

RNA Interference Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “RNA Interference Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 90+ pipeline drugs in the RNA Interference pipeline landscape. It covers the RNA Interference pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Sarcopenia Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Sarcopenia Pipeline Insight 2026” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Sarcopenia pipeline landscape. It covers the Sarcopenia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Sarcopenia therapeutics … Continue reading →

Achondroplasia Therapeutics Market Size was found to be ~USD 600 million in 2025 and It is projected to grow at a CAGR of 11% by 2036

DelveInsight’s “Achondroplasia Market Insights, Epidemiology, and Market Forecast-2036” report delivers an in-depth understanding of the Achondroplasia, historical and forecasted epidemiology as well as the Achondroplasia Market Trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and … Continue reading →

Relapsed/Refractory Acute Myeloid Leukemia Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Relapsed/refractory acute myeloid leukemia Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 75+ pipeline drugs in Relapsed/refractory acute myeloid leukemia (AML) pipeline landscape. It covers the Relapsed/Refractory Acute Myeloid Leukemia pipeline drug profiles, including clinical and … Continue reading →

Monoclonal Antibody Therapeutics Market Size Expected to Reach USD 497.5 Billion by 2029

Monoclonal Antibody Therapeutics Market / mABs Therapeutics Market Size by Production Method (In-Vitro, In-Vivo), Sources (Human, Chimeric), Route of Administration (Intravenous, Subcutaneous), Therapy (Inflammatory & Autoimmune, Oncology, Hematology) – Global Forecast to 2029 Rising Prevalence of Complex Diseases, Biotechnological Advancements, … Continue reading →

Focal Segmental Glomerulosclerosis (FSGS) Market is Expected to Witness Significant Growth by 2034 Owing to the Launch of Novel Targeted Therapies | DelveInsight

The market dynamics for Focal Segmental Glomerulosclerosis (FSGS) are anticipated to witness notable growth driven by increasing disease awareness, rising diagnosis rates, growing understanding of genetic and podocyte-related disease mechanisms, and the emergence of targeted treatment approaches. Additionally, the expected … Continue reading →

Opioid Use Disorder Therapeutics Pipeline Strengthens as 10+ Biopharma Companies Advance Targeted Treatment Strategies

DelveInsight’s “Opioid Use Disorder Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in the Opioid Use Disorder pipeline landscape. Key Takeaways from the Opioid Use Disorder Pipeline Report On May 22, 2026- Eli Lilly … Continue reading →

Leptomeningeal Metastases Therapeutics Market Size (7MM) was ~USD 1700 million in 2024 and It is projected to grow at a significant CAGR by 2034

DelveInsight’s ” Leptomeningeal Metastases Market Insights, Epidemiology, and Market Forecast – 2034″ report delivers an in-depth understanding of Leptomeningeal Metastases, historical and forecasted epidemiology, as well as the Leptomeningeal Metastases Market Trends in the United States, EU4 (Germany, France, Italy, … Continue reading →

Brain Metastases Pipeline Expands as 40+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Brain Metastases Pipeline Insights 2026” report provides comprehensive insights about 40+ Brain Metastases companies and 45+ pipeline drugs in Brain Metastases pipeline landscape. It covers the Brain Metastases pipeline drug profiles, including clinical and nonclinical stage products. Brain Metastases … Continue reading →